KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Gross Profit (2016 - 2025)

Historic Gross Profit for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Biogen's Gross Profit fell 466.55% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.5 billion, marking a year-over-year increase of 164.14%. This contributed to the annual value of $7.5 billion for FY2025, which is 164.14% up from last year.
  • Per Biogen's latest filing, its Gross Profit stood at $1.8 billion for Q4 2025, which was down 466.55% from $1.9 billion recorded in Q3 2025.
  • Over the past 5 years, Biogen's Gross Profit peaked at $2.3 billion during Q2 2021, and registered a low of $1.7 billion during Q1 2024.
  • Moreover, its 5-year median value for Gross Profit was $1.9 billion (2024), whereas its average is $2.0 billion.
  • As far as peak fluctuations go, Biogen's Gross Profit crashed by 2920.65% in 2021, and later soared by 633.7% in 2025.
  • Quarter analysis of 5 years shows Biogen's Gross Profit stood at $2.1 billion in 2021, then fell by 4.85% to $2.0 billion in 2022, then decreased by 10.39% to $1.8 billion in 2023, then increased by 5.84% to $1.9 billion in 2024, then fell by 4.67% to $1.8 billion in 2025.
  • Its Gross Profit stands at $1.8 billion for Q4 2025, versus $1.9 billion for Q3 2025 and $2.0 billion for Q2 2025.